Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
Saved in:
| Title: | Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. |
|---|---|
| Authors: | Cogle CR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Collins B; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Turner D; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Pettiford LC; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Bossé R; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Hawkins KE; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Beachamp Z; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Wise E; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Cline C; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., May WS; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Moreb JS; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Hsu J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Hiemenz J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Brown R; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Norkin M; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Wingard JR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA., Uckun F; Oncotelic Inc, Agoura Hills, CA, USA. |
| Source: | British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (5), pp. e211-e213. Date of Electronic Publication: 2020 Apr 01. |
| Publication Type: | Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32236943 AccessLevel: 2 PubType: Report PubTypeId: report PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Cogle+CR%22">Cogle CR</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Collins+B%22">Collins B</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Turner+D%22">Turner D</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Pettiford+LC%22">Pettiford LC</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Bossé+R%22">Bossé R</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Hawkins+KE%22">Hawkins KE</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Beachamp+Z%22">Beachamp Z</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Wise+E%22">Wise E</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Cline+C%22">Cline C</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22May+WS%22">May WS</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Moreb+JS%22">Moreb JS</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Hsu+J%22">Hsu J</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Hiemenz+J%22">Hiemenz J</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Brown+R%22">Brown R</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Norkin+M%22">Norkin M</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Wingard+JR%22">Wingard JR</searchLink>; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Uckun+F%22">Uckun F</searchLink>; Oncotelic Inc, Agoura Hills, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2020 Jun; Vol. 189 (5), pp. e211-e213. <i>Date of Electronic Publication: </i>2020 Apr 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Letter; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32236943 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.16629 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e211 Titles: – TitleFull: Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cogle CR – PersonEntity: Name: NameFull: Collins B – PersonEntity: Name: NameFull: Turner D – PersonEntity: Name: NameFull: Pettiford LC – PersonEntity: Name: NameFull: Bossé R – PersonEntity: Name: NameFull: Hawkins KE – PersonEntity: Name: NameFull: Beachamp Z – PersonEntity: Name: NameFull: Wise E – PersonEntity: Name: NameFull: Cline C – PersonEntity: Name: NameFull: May WS – PersonEntity: Name: NameFull: Moreb JS – PersonEntity: Name: NameFull: Hsu J – PersonEntity: Name: NameFull: Hiemenz J – PersonEntity: Name: NameFull: Brown R – PersonEntity: Name: NameFull: Norkin M – PersonEntity: Name: NameFull: Wingard JR – PersonEntity: Name: NameFull: Uckun F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2020 Jun Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 189 – Type: issue Value: 5 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |